Sol-Gel Technologies Ltd. (SLGL)
Nasdaq: SLGL · Pharmaceutical Preparations · filing with the SEC since 2016
Who runs Sol-Gel Technologies Ltd.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Arkin Moshe
Chairman of Board and CEO. First filing Mar 2026, latest Mar 18, 2026, 0 filings in all.
Officers reporting now
6
of 11 people with a filing in the last fifteen months
Directors reporting now
5
11 people on the record since 2025
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Arkin Moshe | Chairman of Board and CEO | Mar 2026 | Mar 18, 2026 | none |
| Ben-Or Eyal | Chief Financial Officer | Mar 2026 | Mar 18, 2026 | none |
| Yosef Itzik | Chief Operating Officer | Mar 2026 | Mar 18, 2026 | none |
| Glezin Michael | Chief Business Officer | Mar 2026 | Mar 18, 2026 | none |
| Levy-Hacham Ofra | VP Clinical, Reg & Quality | Mar 2026 | Mar 18, 2026 | none |
| Toledano Ofer | VP Research & Dev. | Mar 2026 | Mar 18, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Arkin Itai Gidon | director | Mar 2026 | Mar 18, 2026 | none |
| Gottfried Ran | director | Mar 2026 | Mar 18, 2026 | none |
| Kochan Sharon | director | Mar 2026 | Mar 18, 2026 | none |
| Lerman Hanna | director | Mar 2026 | Mar 18, 2026 | none |
| Yanai Yuval | director | Mar 2026 | Mar 18, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Opaleye Management Inc. | 10% owner | Nov 2025 | Sep 14, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.